Videolaryngoscope vs VideoLMA for Endotracheal Intubation in RIRS

NCT07555535 | Not Yet Recruiting

• 1 other identifier: AEŞH-EK1-2025-296
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study is a prospective, randomized, parallel-group clinical trial comparing videolaryngoscope and videoLMA for endotracheal intubation in adult patients undergoing surgery. Patients will be randomly assigned into two groups. The primary outcome is intubation time. Secondary outcomes include first attempt success rate, number of attempts, oxygen desaturation, hemodynamic changes, and postoperative complications.

Conditions

Urolithiasis; Airway Management

Outcome Measures

Primary Outcomes (1)

• Intubation Time

  Time from insertion of the airway device into the patient's mouth until successful placement of the endotracheal tube, confirmed by continuous capnography.

  From insertion of the airway device to confirmation of endotracheal tube placement (during anesthesia induction, within approximately 0-5 minutes)

Secondary Outcomes (8)

• First Attempt Success

  During first intubation attempt (within 0-2 minutes)

• Number of Attempts

  During intubation procedure (within approximately 0-10 minutes

• Oxygen Desaturation

  During intubation procedure (from induction until successful intubation, approximately 0-10 minutes)

• Heart rate

  At baseline (pre-induction), immediately after intubation, and at 1, 3, and 5 minutes post-intubation

• Postoperative Sore Throat

  At postoperative 1 hour and 2 hours

Study Arms (2)

Videolaryngoscope Group

EXPERIMENTAL

Patients undergoing endotracheal intubation using videolaryngoscope

Device: Videolaryngoscope

VideoLMA Group

EXPERIMENTAL

Patients undergoing endotracheal intubation using videoLMA

Device: VideoLMA

Interventions

Videolaryngoscope DEVICE

Patients undergoing endotracheal intubation using videolaryngoscope

Videolaryngoscope Group

VideoLMA DEVICE

Patients undergoing endotracheal intubation using videoLMA

VideoLMA Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 18 years and older ASA physical status I-III Patients scheduled for surgery requiring endotracheal intubation Ability to provide written informed consent

You may not qualify if:

• History of tracheostomy Known or predicted difficult airway Presence of oral mass or tumor Pregnant patients Patients unable to provide informed consent Patients requiring reoperation within 24 hours

Sponsors & Collaborators

• Ela Erdem Hıdiroglu: lead

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases

Study Officials

• Ela Erdem Hidiroglu, MD

  Ankara Etlik City Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ela Erdem Hidiroglu, MD

CONTACT

+90 534 887 41 84; drelaerdem@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: this study is conducted as an open label trial no masking is applied the clinicians performing the intubation and collecting the data are aware of the intervention
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: MD, Specialist in Anesthesiology and Reanimation

Study Record Dates

• First Submitted: April 7, 2026
• First Posted: April 29, 2026
• Study Start: April 1, 2026
• Primary Completion: May 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: April 29, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share